Metformin, testosterone therapies lower risk for certain hormone-related cancers in men
Healio, August 23, 2022
In a large cohort of men, pre‐diagnostic use of metformin and testosterone replacement therapy was associated with lower incidence of prostate and colorectal cancers, but not male breast cancer. “The greatest reduced risks of prostate and colorectal cancers were observed when metformin and testosterone replacement therapy were combined,” said Dr. David S. Lopez, associate professor at the University of Texas Medical Branch School of Public and Population Health, told Healio.